Sign In
Buy BEAM
$25.52
-0.97 (-3.66%)
At Close: Jul 31, 2026
How CBD Can Help During The Coronavirus Crisis
02:30pm, Tuesday, 31'st Mar 2020
CBD sales are at an all-time high.
How CBD Can Help During The Coronavirus Crisis
01:58pm, Tuesday, 31'st Mar 2020
CBD sales are at an all-time high.
Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results
10:30am, Monday, 30'th Mar 2020
CAMBRIDGE, Mass., March 30, 2020 -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported.
Beam Therapeutics (NASDAQ:BEAM) & Twist Bioscience (NASDAQ:TWST) Head to Head Review
06:38am, Tuesday, 24'th Mar 2020
Beam Therapeutics (NASDAQ:BEAM) and Twist Bioscience (NASDAQ:TWST) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength o
Beam Therapeutics Announces Key R&D Appointments
11:00am, Monday, 16'th Mar 2020
“As we advance our new class of precision genetic medicines closer to the clinic, we are focused on continuing to expand the scientific leadership at Beam,” said John Evans, chief executive office
Blood disorder startup raises downsized IPO amid market turmoil
05:21pm, Thursday, 12'th Mar 2020
Across the board, companies have contended with a shaky stock market over the last few weeks as the COVID-19 outbreak has spooked investors.
JPMorgan Sees Compelling Value in These 3 Stocks
06:53pm, Thursday, 05'th Mar 2020
The premise is simple; Investors are after plentiful returns. What is entirely more complicated is the execution of the idea. Macrotrends, unforeseen headwinds, internal conflicts and disappointing qu
Cowen likes Amarin in premarket analyst action
01:47pm, Monday, 02'nd Mar 2020
Akero Therapeutics (NASDAQ:AKRO) initiated with Buy rating and $33 (52% upside) price target at H.C. Wainwright.Amarin (NASDAQ:AMRN) initiated with Outperform rating and $23 (57% upside) price target
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
07:52pm, Saturday, 29'th Feb 2020
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 epidemic will likely drag global growth, the viral outbreak proved ad
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
Beam Therapeutics Announces Closing of Initial Public Offering
12:41pm, Tuesday, 11'th Feb 2020
Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the closing of its initial public offering of 12,176,471 shar
Beam Therapeutics Announces Multiple Scientific Advances in its Base Editing Technology Platforms
11:30am, Tuesday, 11'th Feb 2020
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced continued progress in the evolution of its novel adenine bas
Bio Roundup: POTUS on Prices, a16z's Fund, Aimmune's Approval & More
12:48pm, Friday, 07'th Feb 2020
The president’s State of the Union address was wide-ranging, as they tend to be, but those who tuned in heard mention of two hot health policy topics:
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
